← Back to Search

Other

Adductor Canal Block (ACB) Only for Postoperative Pain

Phase 4

Waitlist Available

Led By Carey Breabaker, MD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to two months after surgery

Awards & highlights

Study Summary

This trial will compare the effects of two types of nerve blocks on post-operative pain for patients undergoing ACL reconstruction.

Eligible Conditions

Anterior Cruciate Ligament Injury
Postoperative Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to two months after surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to two months after surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain

Secondary outcome measures

Range of Motion (degrees)

Terminal knee extension (degrees)

total postoperative opioid consumption (total MME)

Trial Design

2Treatment groups

Active Control

Group I: Adductor Canal Block (ACB) OnlyActive Control1 Intervention

Participants randomized to the ACB only group will receive an adductor canal block alone.

Group II: ACB + iPACKActive Control1 Intervention

Participants randomized to the ACB + iPACK group will receive both the ACB and iPACK block.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

932 Previous Clinical Trials

7,394,308 Total Patients Enrolled

2 Trials studying Postoperative Pain

168 Patients Enrolled for Postoperative Pain

Carey Breabaker, MDPrincipal InvestigatorMedical University of South Carolina

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA authorized Adductor Canal Block (ACB) for clinical use?

"There is an abundance of clinical data supporting the safety of Adductor Canal Block (ACB), leading to a score of 3 on our scale. This treatment has already been approved for medical use, rendering it in Phase 4 trials."

Answered by AI

What is the current patient intake for this clinical trial?

"Affirmative. Clinicaltrials.gov documents demonstrate that this clinical trial is currently enrolling individuals, with a first posting date of July 27th 2022 and a most recent edit on August 10th 2022. The study necessitates 82 participants across 1 site."

Answered by AI

Are there opportunities for new participants to join this experiment?

"As per the data hosted on clinicaltrials.gov, this medical trial is proceeding and actively looking for candidates to participate. The study was first published on July 27th 2022 with a recent update occurring in August 10th of that same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

iPACK for Post-op Pain Following ACL Reconstruction

Carey Brewbaker 2022. "iPACK for Post-op Pain Following ACL Reconstruction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05498870.